miR-106b-5p upregulation is associated with microglial activation and inflammation in the mouse hippocampus following

Tao Yu1, Hui Fu1,2, Jing-Jing Sun1

  • 1Department of Pediatrics, Shengjing Hospital of China Medical University, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang City, 110004, Liaoning Province, China.

Experimental Brain Research
|September 3, 2021
PubMed

Insights

MicroRNA-106b-5p and microglial markers increase during status epilepticus (SE) in mice, suggesting potential therapeutic targets. RGMa and TREM2 levels decrease post-SE, with miR-106b-5p interacting with RGMa.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Status epilepticus (SE) is a neurological emergency characterized by prolonged seizures.
  • Neuroinflammation and microglial activation are key pathological processes in SE.
  • The role of specific microRNAs, like miR-106b-5p, in SE-induced neuroinflammation remains underexplored.

Purpose of the Study:

  • To investigate the association of miR-106b-5p with neuroinflammation and microglial activation in a mouse model of SE.
  • To examine the expression patterns of miR-106b-5p, RGMa, TREM2, and key inflammatory markers post-SE.
  • To explore the potential interaction between miR-106b-5p and RGMa.

Main Methods:

  • Lithium-pilocarpine-induced status epilepticus model in female C57BL/6 mice.
  • Assessment of neuronal damage via immunohistochemistry at various time points post-SE.
  • Quantification of miRNA-106b-5p, RGMa, TREM2, and microglia-related markers (IL-1β, IL-4, IL-6, IL-10, iNOS, Arg-1) using molecular assays.
  • Dual luciferase reporter gene assay to confirm direct interaction between miR-106b-5p and RGMa.

Main Results:

  • SE induced neuronal swelling, loss, and apoptosis in the hippocampus, with recovery by day 14.
  • Levels of miR-106b-5p and most microglia-related markers (IL-1β, IL-6, IL-10, iNOS, Arg-1) peaked at 3 days post-SE, indicating inflammation and microglial activation.
  • RGMa and TREM2 levels decreased early post-SE (6 hours), while IL-4 peaked later (7 days).
  • miR-106b-5p demonstrated a direct interaction with RGMa.
  • Most markers returned to baseline by 21 days, except for miR-106b-5p, RGMa, and TREM2.

Conclusions:

  • miR-106b-5p levels are elevated post-SE and associated with neuroinflammation and microglial activation.
  • Decreased RGMa and TREM2 levels correlate with SE-induced inflammation.
  • The miR-106b-5p/RGMa axis may play a role in SE pathogenesis.
  • These findings suggest miR-106b-5p, RGMa, and TREM2 as potential therapeutic targets for SE.

Related Concept Videos